ConductScience.org, home

Paper17124530

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.

Thera MA and 15 others. PLoS Clin Trials, 2006. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial. Papers, record 17124530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17124530

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
PubMed
Journal
PLoS Clin Trials
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2025-05-29
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thera MAMahamadou A
2Doumbo OKOgobara K
3Coulibaly DDrissa
4Diallo DADapa A
5Sagara IIssaka
6Dicko AAlassane
7Diemert DJDavid J
8Heppner DG JrD Gray
9Stewart VAV Ann
10Angov EEvelina
11Soisson LLorraine
12Leach AAmanda
13Tucker KKathryn
14Lyke KEKirsten E
15Plowe CVChristopher V
16Mali FMP1 Working GroupGroup

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
D43 TW001589FIC NIH HHSUnited StatesD43TW001589PubMed and NIHNIH RePORTER
N01 AI085346NIAID NIH HHSUnited StatesN01AI085346PubMed and NIHNIH RePORTER

Download CSV of grants

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112518850Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.Am J Trop Med Hyg2002https://conductscience.org/library/papers/12518850PubMed
21538134Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.J Immunol1992https://conductscience.org/library/papers/1538134PubMed
33079521Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum.J Mol Biol1987https://conductscience.org/library/papers/3079521PubMed
412742586Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.Mol Biochem Parasitol2003https://conductscience.org/library/papers/12742586PubMed
515618165
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Infect Immun2005https://conductscience.org/library/papers/15618165PubMed
616338450Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.Lancet2005https://conductscience.org/library/papers/16338450PubMed
710697894Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria.Parassitologia1999https://conductscience.org/library/papers/10697894PubMed
816356603Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.Vaccine2006https://conductscience.org/library/papers/16356603PubMed
915983925Community permission for medical research in developing countries.Clin Infect Dis2005https://conductscience.org/library/papers/15983925PubMed
108577318Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.Mol Biochem Parasitol1995https://conductscience.org/library/papers/8577318PubMed
1115463788The major merozoite surface protein as a malaria vaccine target.Parasitol Today1993https://conductscience.org/library/papers/15463788PubMed
1215297070Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.Vaccine2004https://conductscience.org/library/papers/15297070PubMed
1315755604Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.Vaccine2005https://conductscience.org/library/papers/15755604PubMed
1416626494A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa.Malar J2006https://conductscience.org/library/papers/16626494PubMed
1515488216Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.Lancet2004https://conductscience.org/library/papers/15488216PubMed
168368766Adjuvant activity of QS-21 isomers.Ann N Y Acad Sci1993https://conductscience.org/library/papers/8368766PubMed
1716388879Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.Vaccine2007https://conductscience.org/library/papers/16388879PubMed

Download CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
39025972Malaria vaccines: a new era of prevention and control.Nat Rev Microbiol2024https://conductscience.org/library/papers/39025972PubMed
33789984Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2-Based Antigen in a Trivalent, Multistage Malaria Vaccine.J Immunol2021https://conductscience.org/library/papers/33789984PubMed
32348377Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.PLoS One2020https://conductscience.org/library/papers/32348377PubMed
32127565Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination.Sci Rep2020https://conductscience.org/library/papers/32127565PubMed
30658710Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A.Malar J2019https://conductscience.org/library/papers/30658710PubMed
30621160Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities.Molecules2019https://conductscience.org/library/papers/30621160PubMed
29062081An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.Sci Rep2017https://conductscience.org/library/papers/29062081PubMed
28993460Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate.Infect Immun2018https://conductscience.org/library/papers/28993460PubMed
27852258Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.Malar J2016https://conductscience.org/library/papers/27852258PubMed
26833236Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.FEMS Microbiol Rev2016https://conductscience.org/library/papers/26833236PubMed
26475447Designing malaria vaccines to circumvent antigen variability.Vaccine2015https://conductscience.org/library/papers/26475447PubMed
25918203Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women.Am J Trop Med Hyg2015https://conductscience.org/library/papers/25918203PubMed
25294612Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria.Am J Trop Med Hyg2015https://conductscience.org/library/papers/25294612PubMed
25238721Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.Malar J2014https://conductscience.org/library/papers/25238721PubMed
24354660Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-142 (MSP-142).Malar J2013https://conductscience.org/library/papers/24354660PubMed
23911334Transplacentally transferred functional antibodies against Plasmodium falciparum decrease with age.Acta Trop2013https://conductscience.org/library/papers/23911334PubMed
23897613A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies.Infect Immun2013https://conductscience.org/library/papers/23897613PubMed
23342996
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Malar J2013https://conductscience.org/library/papers/23342996PubMed
23146673A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.Vaccine2013https://conductscience.org/library/papers/23146673PubMed
22958482Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.Malar J2012https://conductscience.org/library/papers/22958482PubMed

See all 39 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17124530

GET https://conductscience.org/api/papers/v1/17124530/cited_by?page=2